N4-Hydroxycytidine
Catalogue Number: CV-1029-2-RPE
| Manufacturer: | rPeptide |
| Physical state: | Lyophilized |
| Type: | Biochemicals |
| Shipping Condition: | RT |
| Unit(s): | 25 mg |
Description
Description: N4-Hydroxycytidine was originally identified as a mutagen effecting AT to GC base-pair transitions. It has also been found to have antiviral properties against a broad range of viruses including hepatitis C, norovirus, Ebola virus, influenza and respiratory syncytial viruses and coronaviruses. Active molecule in the antiviral pro-drug clinical candidate EIDD-2801.
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations